The “PSOST”: Providers' Signout for Scope of Treatment
Kristina Newport(Pennsylvania State University), Thomas J. Smith(Sidney Kimmel Cancer Center), Barton T. Bobb, Shejal Patel(Dana-Farber Cancer Institute), Patrick J. Coyne(Medical University of South Carolina), Laurie Lyckholm(Virginia Commonwealth University Medical Center)
Cited by 6
Related Papers
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2009|913
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
|Journal of Clinical Oncology|2015|903
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
|Journal of Clinical Oncology|2015|896